Search is Powered by Google
MRSA / Drug Resistance News

In The Battle Against Hospital Infections 'Crime Scene Investigation' Methods Could Help

Main Category: MRSA / Drug Resistance
Also Included In: Public Health;  Liver Disease / Hepatitis
Article Date: 23 Apr 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Inspired by the popular television drama CSI, investigators in the Netherlands have trialed methods used by forensic scientists at crime scenes to highlight infection risks in their hospital. Researchers at Deventer Hospital used Luminol, a chemical used by crime scene investigators, to detect traces of blood in their haemodialysis unit. Luminol reacts with microscopic amounts of blood to produce bright blue luminescence, which allows investigators to track invisible blood splashes in the environment. The results of this experiment are reported in a new study, published in the Journal of Hospital Infection (http://www.elsevier.com/locate/jhin).

Bergervoet et al tested their apparently clean unit with Luminol. They found traces of blood on many surfaces including cupboard handles, telephones, computer keyboards, side tables and the floor, even though some of these surfaces had been cleaned. They expect that these results can be reproduced in other hospitals that plan to use Luminol in the future as described in their paper.

The group of researchers suggests that following on from their research, Luminol could be used as part of a hospital infection control regimen, in order to highlight risks associated with the contamination of the hospital environment with blood. Bergervoet et al specifically discuss the possibility that the hepatitis C virus may be transmitted via such environmental contamination.

Corresponding author Dr Paul Bergervoet of Deventer Ziekenhuis commented: "The aim of this article is to introduce this method to the infection control professionals so it can be used to monitor cleaning and disinfection procedures and alert healthcare workers to the possibility of contamination of the hospital environment with blood."

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

"Application of the forensic Luminol for blood and infection control" by PWM Bergervoet, N van Riessen, FW Sebens and WC van der Zwet,appears in the Journal of Hospital Infection, doi:10.1016/j.jhin.2008.01.026, published by Elsevier on behalf of the Hospital Infection Society.

For further commentary, please contact: Dre Paul Bergervoet, Department of Infection Control, Deventer Ziekenhuis, PO Box 5001, 7400 GC Deventer, The Netherlands.

Journal of Hospital Infection

Journal of Hospital Infection
(JHI) is published by Elsevier on behalf of the Hospital Infection Society http://www.his.org.uk/ on a monthly basis. The Journal publishes original articles in the field of hospital-acquired infection and related subjects. JHI seeks to promote collaboration between the many disciplines in infection control in different countries resulting in multidisciplinary and international coverage of the latest developments in this crucial area.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Source: Catherine O'Hara
Elsevier




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Breast Cancer Cardiovascular GI Prostate Cancer Psychiatry Respiratory Learning Resources Migraine Urology
Asthma Bipolar Blood Pressure Breast Cancer (Patient) Heartburn

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Treating Allergic Asthma
Treating Allergic Asthma

Cheryl has suffered from asthma and allergies her whole life. Since her asthma didn't respond well to most treatments, she lived in fear of the next attack. But a new treatment specifically targeting the allergic response that causes her asthma has changed her life.

more videos are available in our health videos section.

Add Your Advertisement Here